Call of the wild: Singapore businesses still keen on emerging markets

IT WAS late 2019, and Singapore biotech startup Stratificare was all set to begin clinical studies in partnership with experts in Mexico, for a test that might prove able to predict severe cases of dengue.

The tie-up arose from Stratificare's participation in a business delegation accompanying Prime Minister Lee Hsien Loong on his official visit to that country.

But the novel coronavirus hit – and that made it “very difficult for us to run any clinical study there”, Stratificare chief executive Anthony Chua told The Business Times.